Literature DB >> 27663056

RYR1-related rhabdomyolysis: A common but probably underdiagnosed manifestation of skeletal muscle ryanodine receptor dysfunction.

N C Voermans1, M Snoeck2, H Jungbluth3.   

Abstract

Mutations in the skeletal muscle ryanodine receptor (RYR1) gene are associated with a wide spectrum of inherited myopathies presenting throughout life. Malignant hyperthermia susceptibility (MHS)-related RYR1 mutations have emerged as a common cause of exertional rhabdomyolysis, accounting for up to 30% of rhabdomyolysis episodes in otherwise healthy individuals. Common triggers are exercise and heat and, less frequently, viral infections, alcohol and drugs. Most subjects are normally strong and have no personal or family history of malignant hyperthermia. Heat intolerance and cold-induced muscle stiffness may be a feature. Recognition of this (probably not uncommon) rhabdomyolysis cause is vital for effective counselling, to identify potentially malignant hyperthermia-susceptible individuals and to adapt training regimes. Studies in various animal models provide insights regarding possible pathophysiological mechanisms and offer therapeutic perspectives.
Copyright © 2016. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Exercise; Exertional rhabdomyolysis; Genetic; Myopathy; Rhabdomyolysis; Ryanodine receptor (RyR1); Skeletal muscle ryanodine receptor (RYR1) gene

Mesh:

Substances:

Year:  2016        PMID: 27663056     DOI: 10.1016/j.neurol.2016.07.018

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  11 in total

1.  RYR1 and CACNA1S genetic variants identified with statin-associated muscle symptoms.

Authors:  Paul J Isackson; Jianxin Wang; Mohammad Zia; Paul Spurgeon; Adrian Levesque; Jonathan Bard; Smitha James; Norma Nowak; Tae Keun Lee; Georgirene D Vladutiu
Journal:  Pharmacogenomics       Date:  2018-10-16       Impact factor: 2.533

2.  Interactions of Dichlorodiphenyltrichloroethane (DDT) and Dichlorodiphenyldichloroethylene (DDE) With Skeletal Muscle Ryanodine Receptor Type 1.

Authors:  Kim M Truong; Gennady Cherednichenko; Isaac N Pessah
Journal:  Toxicol Sci       Date:  2019-08-01       Impact factor: 4.849

Review 3.  Pathophysiology of heatstroke in dogs - revisited.

Authors:  Yaron Bruchim; Michal Horowitz; Itamar Aroch
Journal:  Temperature (Austin)       Date:  2017-10-09

4.  Comparison of Chlorantraniliprole and Flubendiamide Activity Toward Wild-Type and Malignant Hyperthermia-Susceptible Ryanodine Receptors and Heat Stress Intolerance.

Authors:  Kim M Truong; Isaac N Pessah
Journal:  Toxicol Sci       Date:  2019-02-01       Impact factor: 4.849

5.  Myotoxicity Induced by Antiepileptic Drugs: Could be a Rare but Serious Adverse Event?

Authors:  Antonio Siniscalchi; Scott Mintzer; Giovambattista De Sarro; Luca Gallelli
Journal:  Psychopharmacol Bull       Date:  2021-11-03

Review 6.  Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept.

Authors:  Sheila Riazi; Natalia Kraeva; Philip M Hopkins
Journal:  Anesthesiology       Date:  2018-01       Impact factor: 7.892

7.  Dietary Caffeine Synergizes Adverse Peripheral and Central Responses to Anesthesia in Malignant Hyperthermia Susceptible Mice.

Authors:  Monica Aleman; Rui Zhang; Wei Feng; Lihong Qi; Jose R Lopez; Chelsea Crowe; Yao Dong; Genady Cherednichenko; Isaac N Pessah
Journal:  Mol Pharmacol       Date:  2020-08-06       Impact factor: 4.436

8.  RYR1 causing distal myopathy.

Authors:  Ruple S Laughlin; Zhiyv Niu; Eric Wieben; Margherita Milone
Journal:  Mol Genet Genomic Med       Date:  2017-10-04       Impact factor: 2.183

9.  Congenital myopathies in the adult neuromuscular clinic: Diagnostic challenges and pitfalls.

Authors:  Stefan Nicolau; Teerin Liewluck; Jennifer A Tracy; Ruple S Laughlin; Margherita Milone
Journal:  Neurol Genet       Date:  2019-06-04

Review 10.  Update on Congenital Myopathies in Adulthood.

Authors:  George Konstantinos Papadimas; Sophia Xirou; Evangelia Kararizou; Constantinos Papadopoulos
Journal:  Int J Mol Sci       Date:  2020-05-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.